Prescreening Study to Identify Potential Participants for ACDN-01 Clinical Trials

Recruiting

ACDN-01Prescreening Study to Identify Potential Participants for ACDN-01 Clinical Trials

Sponsor:

Ascidian Therapeutics, Inc

Code:

NCT06445322

Conditions

Stargardt Disease

Stargardt Disease 1

Cone Rod Dystrophy

Juvenile Macular Degeneration

Eligibility Criteria

Sex: All

Age: 5+

Healthy Volunteers: Not accepted

Interventions

Prescreening Assessments

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-26. This information was provided to ClinicalTrials.gov by Ascidian Therapeutics, Inc on 2025-01-22.